Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Overview
- Porter’s Five Forces Analysis
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Potential for New Entrants
- Threat of Substitutes
- Competitiveness in the Industry
Chapter 3 Market Dynamics
- Overview
- Market Drivers
- Growing Focus on Ethical Alternatives to Animal Testing
- Increasing Demand for Tumor Modeling and Biobanking Fuel Market Expansion
- Increasing Adoption of Organoid Technology for Wider Applications
- Market Restraints
- Strict Government Regulations Governing Cell Cultures and Stem Cells R&D
- Challenges in Incorporating Organoids into Existing Research Practices
- Market Opportunities
- Applications in Drug Development, Personalized Medicine, and Transplantation
Chapter 4 Regulatory Landscape
- Regulatory Scenarios
- United States
- EU
- U.K.
- Germany
- India
Chapter 5 Emerging Technologies
- Overview
- 3D Printing
- Microfluidics
- Artificial Intelligence and Automation
- Patent Analysis
Chapter 6 Market Segmentation Analysis
- Segmentation Breakdown
- Global Market for Laboratory Animal Models, 3D Cultures and Organoids, by Animal Model
- Animal Models
- Global Market Size and Forecast
- Mice
- Rats
- Rabbits
- Hamsters
- Guinea Pigs
- Others
- Global Market for Laboratory Animal Models, 3D Cultures and Organoid, by 3D Cultures
- 3D Cultures
- Global Market Size and Forecast
- Organ-on-chip
- Organoids
- Intestine
- Liver
- Stomach
- Pancreas
- Lung
- Kidney
- Others
- Spheroids
- Global Market for Laboratory Animal Models, 3D Cultures and Organoids by Application
- Developmental Biology
- Drug Discovery and Personalized Medicine
- Regenerative Medicine
- Pathology of Infectious Disease
- Drug Toxicity and Efficacy Testing
- Others
- Geographic Breakdown
- Global Market for Laboratory Animal Models, 3D Cultures and Organoids by Region
- Global Market Size and Forecast
- North America
- U.S.
- Canada
- Market Size and Forecast
- Europe
- Germany
- U.K.
- Market Size and Forecast
- Asia-Pacific
- Rest of the World
Chapter 7 Competitive Intelligence
- Competitive Landscape
- Strategic Analysis
Chapter 8 Sustainability in Laboratory Animal Models, 3D Cultures, and Organoids: An ESG Perspective
- Introduction to ESG
- Sustainability in the Market
- ESG Perspective
- Environmental Impact
- Social Impact
- Governance
List of Tables
Summary Table: Global Market for Laboratory Animal Models, 3D Cultures, and Organoids, by Segment, Through 2029
Table 1: Animal Model vs. 3D Cell Culture
Table 2: Porter’s Five Forces Analysis: Laboratory Animal Models, 3D Cultures, and Organoids
Table 3: Patent Analysis for 3D Cell Culture
Table 4: Global Market for Animal Models, by Animal Type, Through 2029
Table 5: Global Market for Mice Animal Models, by Region, Through 2029
Table 6: Global Market for Rat Animal Models, by Region, Through 2029
Table 7: Global Market for Rabbit Animal Models, by Region, Through 2029
Table 8: Global Market for Hamster Animal Models, by Region, Through 2029
Table 9: Global Market for Guinea Pig Animal Models, by Region, Through 2029
Table 10: Global Market for Other Animal Models, by Region, Through 2029
Table 11: Global Market for 3D Cell Cultures, by 3D Type, Through 2029
Table 12: Global Market for Organ-on-chips in 3D Cultures, by Region, Through 2029
Table 13: Global Market for Organoids in 3D Cultures, by Organ Type, Through 2029
Table 14: Global Market for Organoid in 3D Cultures, by Region, Through 2029
Table 15: Global Market for Intestines in Organoids, by Region, Through 2029
Table 16: Global Market for Livers in Organoids, by Region, Through 2029
Table 17: Global Market for Stomachs in Organoids, by Region, Through 2029
Table 18: Global Market for Pancreases in Organoids, by Region, Through 2029
Table 19: Global Market for Lungs in Organoids, by Region, Through 2029
Table 20: Global Market for Kidneys in Organoids, by Region, Through 2029
Table 21: Global Market for Other in Organoids, by Region, Through 2029
Table 22: Global Market for Spheroids in 3D Cultures, by Region, Through 2029
Table 23: Global Market for Laboratory Animal Models, 3D Cultures, and Organoids, by Application, Through 2029
Table 24: Global Market for Developmental Biology in Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029
Table 25: Global Market for Drug Discovery and Personalized Medicine in Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029
Table 26: Global Market for Regenerative Medicine in Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029
Table 27: Global Market for Pathology of Infectious Diseases in Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029
Table 28: Global Market for Drug Toxicity and Efficacy Testing in Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029
Table 29: Global Market for Other Applications in Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029
Table 30: Global Market for Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029
Table 31: North American Market for Laboratory Animal Models, 3D Cultures and Organoids, by Segment, Through 2029
Table 32: North American Market for 3D Cell Cultures, by Type, Through 2029
Table 33: North American Market for Laboratory Animal Models, 3D Cultures and Organoids, by Applications, Through 2029
Table 34: European Market for Laboratory Animal Models, 3D Cultures and Organoids, by Segment, Through 2029
Table 35: European Market for 3D Cell Cultures, by Type, Through 2029
Table 36: European Market for Laboratory Animal Models, 3D Cultures and Organoids, by Applications, Through 2029
Table 37: Asia-Pacific Market for Laboratory Animal Models, 3D Cultures and Organoids, by Segment, Through 2029
Table 38: Asia-Pacific Market for 3D Cell Cultures, by Type, Through 2029
Table 39: Asia-Pacific Market for Laboratory Animal Models, 3D Cultures and Organoids, by Applications, Through 2029
Table 40: Rest of the World Market for Laboratory Animal Models, 3D Cultures and Organoids, by Segment, Through 2029
Table 41: Rest of the World Market for 3D Cell Cultures, by Type, Through 2029
Table 42: Rest of the World Market for Laboratory Animal Models, 3D Cultures and Organoids, by Applications, Through 2029
Table 43: Global Company Rankings in the Market for Laboratory Animal Models, 3D Cultures and Organoids, 2023
Table 44: Key ESG Metrics Focus Areas
Table 45: ESG Rankings for CRO Services, 2023
Table 46: Abbreviations Used in this Report
Table 47: Report Sources
Table 48: 3D Biotek LLC.: Company Snapshot
Table 49: 3D Biotek LLC.: Product Portfolio
Table 50: Bio-Techne: Company Snapshot
Table 51: Bio-Techne: Financial Performance, FY 2022 and 2023
Table 52: Bio-Techne: Product Portfolio
Table 53: Bio-Techne: News/Key Developments, 2022
Table 54: Cellink: Company Snapshot
Table 55: Cellink: Product Portfolio
Table 56: Cellink: News/Key Developments, 2023
Table 57: Charles River Laboratories: Company Snapshot
Table 58: Charles River Laboratories: Financial Performance, FY 2022 and 2023
Table 59: Charles River Laboratories: Products Portfolio
Table 60: Charles River Laboratories: News/Key Developments, 2023
Table 61: Cherry Biotech: Company Snapshot
Table 62: Cherry Biotech: Product Portfolio
Table 63: Corning Inc.: Company Snapshot
Table 64: Corning Inc.: Financial Performance, FY 2022 and 2023
Table 65: Corning Inc.: Product Portfolio
Table 66: Corning Inc.: News/Key Developments, 2022-2024
Table 67: Emulate: Company Snapshot
Table 68: Emulate: Product Portfolio
Table 69: Emulate: News/Key Developments, 2021-2023
Table 70: genOway: Company Snapshot
Table 71: genOway: Financial Performance, FY 2022 and 2023
Table 72: genOway: Product Portfolio
Table 73: genOway: News/Key Developments, 2021 and 2022
Table 74: Greiner Bio-One International GmbH: Company Snapshot
Table 75: Greiner Bio-One International GmbH: Product Portfolio
Table 76: InSphero: Company Snapshot
Table 77: InSphero: Product Portfolio
Table 78: InSphero: News/Key Developments, 2023
Table 79: MatTek: Company Snapshot
Table 80: MatTek: Product Portfolio
Table 81: Mimetas B.V.: Company Snapshot
Table 82: Mimetas B.V.: Product Portfolio
Table 83: Mimetas B.V.: News/Key Developments, 2023-2024
Table 84: PepGel LLC.: Company Snapshot
Table 85: PepGel LLC.: Product Portfolio
Table 86: Poietis: Company Snapshot
Table 87: Poietis: Product Portfolio
Table 88: Poietis: News/Key Developments, 2024
Table 89: Taconic Biosciences Inc.: Company Snapshot
Table 90: Taconic Biosciences Inc.: Product Portfolio
Table 91: TheWell Bioscience Inc.: Company Snapshot
Table 92: TheWell Bioscience Inc.: Product Portfolio
Table 93: TheWell Bioscience Inc.: News/Key Developments, 2023-2024
Table 94: Thermo Fisher Scientific Inc.: Company Snapshot
Table 95: Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 96: Thermo Fisher Scientific Inc.: Product Portfolio
List of Figures
Summary Figure: Global Market Shares of Laboratory Animal Models, 3D Cultures, and Organoids, by Segment, 2021-2029
Figure 1: Animal Modelling for Drug Discovery
Figure 2: Evolution of 3D Cell Culture
Figure 3: Market Dynamics of Laboratory Animal Models, 3D Cultures, and Organoids
Figure 4: Global Market Shares of Animal Models, by Animal Type, 2023
Figure 5: Global Market Shares of Mice Animal Models, by Region, 2023
Figure 6: Global Market Shares of Rat Animal Models, by Region, 2023
Figure 7: Global Market Shares of Rabbit Animal Models, by Region, 2023
Figure 8: Global Market Shares of Hamster Animal Models, by Region, 2023
Figure 9: Global Market Shares of Guinea Pig Animal Models, by Region, 2023
Figure 10: Global Market Shares of Other Animal Models, by Region, 2023
Figure 11: Types of 3D Cell Culture Utilized in Drug Discovery
Figure 12: Global Market Shares of 3D Cell Cultures, by 3D Type, 2023
Figure 13: Global Market Shares of Organ-on-chips in 3D Cultures, by Region, 2023
Figure 14: Global Market Shares of Organoids in 3D Cultures, by Organ Type, 2023
Figure 15: Global Market Shares of Organoid in 3D Cultures, by Region, 2023
Figure 16: Global Market Shares of Intestines in Organoids, by Region, 2023
Figure 17: Global Market Shares of Livers in Organoids, by Region, 2023
Figure 18: Global Market Shares of Livers in Organoids, by Region, 2023
Figure 19: Global Market Shares of Pancreases in Organoids, by Region, 2023
Figure 20: Global Market Shares of Lungs in Organoids, by Region, 2023
Figure 21: Global Market Shares of Kidneys in Organoids, by Region, 2023
Figure 22: Global Market Shares of Other in Organoids, by Region, 2023
Figure 23: Global Market Shares of Spheroids in 3D Cultures, by Region, 2023
Figure 24: Global Market Shares of Laboratory Animal Models, 3D Cultures, and Organoids, by Application, 2023
Figure 25: Global Market Shares of Developmental Biology in Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023
Figure 26: Global Market Shares of Drug Discovery and Personalized Medicine in Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023
Figure 27: Global Market Shares of Regenerative Medicine in Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023
Figure 28: Global Market Shares of Pathology of Infectious Diseases in Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023
Figure 29: Global Market Shares of Drug Toxicity and Efficacy Testing in Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023
Figure 30: Global Market Shares of Other Applications in Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023
Figure 31: Global Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023
Figure 32: North American Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Segment, 2023
Figure 33: North American Market Shares of 3D Cell Cultures, by Type, 2023
Figure 34: North American Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Country, 2023
Figure 35: European Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Segmen, 2023
Figure 36: European Market Shares of 3D Cell Cultures, by Type, 2023
Figure 37: European Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Country, 2023
Figure 38: Asia-Pacific Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Segment, 2023
Figure 39: Asia-Pacific Market Shares of 3D Cell Cultures, by Type, 2023
Figure 40: Asia-Pacific Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Country, 2023
Figure 41: Rest of the World Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Segment, 2023
Figure 42: Rest of the World Market Shares of 3D Cell Cultures, by Type, 2023
Figure 43: Rest of the World Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023
Figure 44: Pillars of ESG
Figure 45: Advantages of ESG for Companies
Figure 46: Bio-Techne: Revenue Shares, by Segment, 2023
Figure 47: Bio-Techne: Revenue Shares, by Country/Region, 2023
Figure 48: Charles River Laboratories: Revenue Shares, by Business Unit, FY 2023
Figure 49: Charles River Laboratories: Revenue Shares, by Country/Region, FY 2023
Figure 50: Corning Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 51: Corning Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 52: Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 53: Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2023
